Brief: Freeline Therapeutics Holdings Posts Quarterly Loss Per Share Of $0.98

Freeline Therapeutics Holdings

17/05/2021 21:26

May 17 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * FREELINE THERAPEUTICS HOLDINGS PLC - CASH AND CASH
EQUIVALENTS
WERE $195.8 MILLION AS OF MARCH 31, 2021, AS COMPARED TO $230.0
MILLION AS OF DECEMBER 31, 2020
    * FREELINE THERAPEUTICS HOLDINGS PLC - EXPECTS CURRENT LEVEL
OF
CASH AND CASH EQUIVALENTS WILL ENABLE COTO FUND ITS OPERATING
EXPENSES INTO Q3 OF 2022
    * FREELINE THERAPEUTICS HOLDINGS PLC - QTRLY LOSS PER SHARE
$0.98

Source text for Eikon:  ID:nGNX8rcLnM 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))